Adaptimmune Therapeutics PLC to Provide Clinical and Business Update Call Transcript
Good day, ladies and gentlemen, and welcome to the Adaptimmune Clinical and Business Update. (Operator Instructions) As a reminder, this conference call is being recorded.
I would now like to introduce your host for today's conference, Ms. Juli Miller. You may begin.
Hi, good morning, and welcome to Adaptimmune's webcast during which we will summarize our most recent clinical data and next steps for the company. We will present slides during this webcast, and there is a link to join on the IR tab of our website. The link is also available in the press release we issued at 7:00 a.m. this morning that provides an overview of our clinical update. The slides are available on the IR tab of our website for your reference as well.
Earlier this morning, we issued two press releases, one detailing our most recent clinical data and a second providing updated financial information based on our Q1 2019 results. To be clear, this morning's webcast will focus on our latest clinical data and the
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |